Quantcast

Latest Chronic kidney disease Stories

2014-02-17 04:22:35

Signs agreement to treat half the dialysis patients currently under care of Saudi Arabia's Ministry of Health RIYADH, Saudi Arabia, Feb. 17, 2014 /PRNewswire/ -- DaVita, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, today announced it has signed a major tender from the Kingdom of Saudi Arabia's Ministry of Health to treat half of the approximately 10,000 dialysis patients currently under the Ministry's care. (Photo:...

2014-02-07 12:58:48

Patients who experience abrupt kidney injury following surgery have an increased risk of later developing heart problems, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that properly treating and monitoring patients with acute kidney injury (AKI) could help protect their heart health. AKI, an sudden decline in kidney function, is an increasingly prevalent and potentially serious condition in hospitalized...

2014-01-28 12:30:02

The CKD Market Will Decline Through 2017, Due to Genericization of Expensive Agents and Reimbursement Constraints in the U.S., According to Findings from Decision Resources Group BURLINGTON, Mass., Jan. 28, 2014 /PRNewswire/ -- Decision Resources Group finds that, after an initial decline driven by generic and biosimilar competition in the G7 markets and changes in reimbursement practices in the United States, the total chronic kidney disease (CKD) market will return to growth, achieving...

2014-01-21 23:01:30

Brian Radbill, MD, FACP, a 15-year veteran of the Mount Sinai Health System, has been named Chief Medical Officer and Vice President of Medical Affairs for Mount Sinai Queens. New York, NY (PRWEB) January 21, 2014 Brian Radbill, MD, FACP, a 15-year veteran of the Mount Sinai Health System, has been named Chief Medical Officer and Vice President of Medical Affairs for Mount Sinai Queens. In that position, Dr. Radbill will oversee the delivery of high-quality, patient-focused medical care...

2014-01-21 16:25:38

NEW YORK, Jan. 21, 2014 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced that it has commenced a $90 million underwritten public offering of shares of its common stock. In connection with this offering, Keryx expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. J.P. Morgan is acting as the sole book-running manager in the...

2014-01-16 04:20:40

GLENDALE, Calif., Jan. 16, 2014 /PRNewswire-USNewswire/ -- Prom season comes early for hundreds of teens and young adults (14 to 24 years old) who have kidney disease, who are on dialysis or who have had a transplant. Renal Support Network (RSN) steps out onto the dance floor Sunday, January 19, 2014, to host the 15(th) Annual Renal Teen Prom for these teens and their guests. Last week attendees and guests took their pick of evening gowns that were donated especially for the event. This...

2014-01-13 04:20:59

STOCKHOLM, January 13, 2014 /PRNewswire/ -- Pharmalink AB, a specialty pharma company focused on orphan and niche products, announces it has completed recruitment of patients into a Phase IIb NEFIGAN study of its orphan drug product, Nefecon(R) (http://www.nefigan.net). Pharmalink expects to announce top-line results in mid-2015. The Phase IIb study is a multi-center, randomized, double-blinded placebo-controlled clinical trial designed to assess the efficacy and safety...

2014-01-10 16:21:55

DUBLIN, January 10, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/j635wj/nephrology_and) has announced the addition of the "2013 Report on the International Nephrology and Urology Devices Market - Industry Analysis, Size, Share, Trends and Forecast to 2018" [http://www.researchandmarkets.com/research/j635wj/nephrology_and ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )...

2014-01-08 23:24:51

Proprietary Renal Nutrition Supplement Approved Philadelphia, PA (PRWEB) January 08, 2014 In a move to expand its geographic reach to international markets and further implement the strategic growth plan of the company, Pentec Health, Inc. today announced that it has been awarded a patent by the Intellectual Property Office of Australia for its specialty pharmacy compounded prescription renal formulation, PROPLETE®. Proplete® is a proprietary Intradialytic Parenteral Nutrition...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related